Guidelines: DEGRO Guidelines (Germany): Difference between revisions
No edit summary |
m (Update categories.) |
||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span> | |||
Go back to [[Germany]] page | Go back to [[Germany]] page | ||
| Line 12: | Line 12: | ||
'''Access to information:''' [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to access]. | '''Access to information:''' [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to access]. | ||
<span style="display:none">Esophagus</span> | |||
<span style="display:none">Stomach</span> | |||
<span style="display:none">Small intestine</span> | |||
<span style="display:none">Large intestine</span> | |||
<span style="display:none">Rectum</span> | |||
<span style="display:none">Anus</span> | |||
<span style="display:none">Liver</span> | |||
<span style="display:none">Gallbladder</span> | |||
<span style="display:none">Bile ducts</span> | |||
<span style="display:none">Pancreas</span> | |||
<span style="display:none">Colon</span> | |||
<span style="display:none">Lung</span> | |||
<span style="display:none">Trachea</span> | |||
<span style="display:none">Bronchi</span> | |||
<span style="display:none">Pleura</span> | |||
<span style="display:none">Mediastinum</span> | |||
<span style="display:none">Eye</span> | |||
<span style="display:none">Brain</span> | |||
<span style="display:none">Spinal cord</span> | |||
<span style="display:none">Kidney</span> | |||
<span style="display:none">Ureter</span> | |||
<span style="display:none">Bladder</span> | |||
<span style="display:none">Urethra</span> | |||
<span style="display:none">Peritoneum</span> | |||
<span style="display:none">Pericardium</span> | |||
<span style="display:none">Retroperitoneum</span> | |||
<span style="display:none">Mesothelium</span> | |||
<span style="display:none">dataOwner::DEGRO</span> | |||
<span style="display:none">availableVariable::medical procedures</span> | |||
<span style="display:none">availableVariable::diagnosis</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
Revision as of 13:25, 2 December 2025
Go back to Germany page
Primary purpose: To establish evidence-based practices for the use of stereotactic radiotherapy and radiosurgery.
Sponsor, manager or home institution: DEGRO.
Type of information: Detailed protocols and evidence-based recommendations for conducting stereotactic radiotherapy and radiosurgery, focusing on specific conditions like brain metastases, early-stage non-small cell lung cancer (NSCLC), primary and secondary liver cancer, renal and pancreatic cancer, and ventricular tachycardia. These include best practices for treatment planning, dosing, patient selection, and outcomes assessment. medical procedures; diagnosis. Click here to learn more.
Cancer areas of interest: C15-C26: Digestive system cancers; C30-C39: Lung/chest cancers; C69-C72: Eye and brain cancer; C64-C68: Urinary system cancers; C76-C80: Cancers of unknown or unspecified areas. Click here to learn more.
Access to information: Click here to access.